Combined fulminant frontotemporal dementia and amyotrophic lateral sclerosis associated with an I113T SOD1 mutation

Amyotrophic Lateral Sclerosis

Volumn 13, Issue 6, 2012, Pages 567-569

  Katz, Jonathan S ^a   Katzberg, Hans D ^b   Woolley, Susan C ^a   Marklund, Stefan L ^c   Andersen, Peter M ^c  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyotrophic lateral sclerosis; Frontotemporal dementia; Superoxide dismutase type 1

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; APATHY; APHASIA; APRAXIA; ARTICLE; ATROPHY; BEHAVIOR DISORDER; BRAIN ATROPHY; CASE REPORT; COGNITIVE DEFECT; CONTROLLED STUDY; DENERVATION; DYSPHAGIA; ELECTROMYOGRAM; ENZYME ACTIVITY; ERYTHROCYTE; EXECUTIVE FUNCTION; EXON; FASCICULATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HETEROZYGOTE; HUMAN; HYPERREFLEXIA; LIMB WEAKNESS; MALE; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RESPIRATORY FAILURE; SPEECH DISORDER; WEIGHT REDUCTION;

AMYOTROPHIC LATERAL SCLEROSIS; FRONTOTEMPORAL DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; SUPEROXIDE DISMUTASE;

EID: 84866127864     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2012.678365     Document Type: Article

References (18)

1. Battistini S, Giannini F, Greco G, Bibb ò G, Ferrera L, Marini V, et al. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicentre Italian study. J Neurol. 2005;252:782-8.
2. Mas è G, Ros S, Gemma A, Bonfi gli L, Carraro N, Cazzato G, et al. ALS with variable phenotypes in a six-generation family caused by leu144phe mutation in the SOD1 gene. J Neurol Sci. 2001;191:11-8.
3. Lopate G, Baloh RH, Al-Lozi MT, Miller TM, Fernandes Filho JA, Ni O, et al. Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation. Amyotroph Lateral Scler. 2010;11:232-6.
4. Wicks P, Abrahams S, Papps B, Al-Chalabi A, Shaw CE, Leigh PN, et al. SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis. J Neurol. 2009;256:234-41.
5. Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10:131-46.
6. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al. Expanded GGGGCC hexanucleotide repeat in non-coding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245-56.
7. Kovacs GG, Murrell JR, Horvath S, Haraszti L, Majtenyi K, Molnar MJ, et al. TARDP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov Disord. 2009;24:1843-7.
8. Blair IP, Williams KL, Warraich ST, Durnall JC, Thoeng AD, Manavis J, et al. FUS mutations in amyotrophic lateral sclerosis: Clinical, pathological, neurophysiological and genetic analysis. J Neurol Neurosurg Psychiatry. 2010;81:639-45.
9. van Es MA, Diekstra FP, Veldink JH, Baas F, Bourque PR, Schelhaas HJ, et al. A case of ALS-FTD in a large FALS pedigree with a K17/ANG mutation. Neurology. 2009;72: 287-8.
10. Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlstr ö m H, et al. Sigma non-opioid receptor 1 mutations cause frontotemporal lobar degenerationmotor neuron disease. Ann Neurol. 2010;68:639-49.
11. Osawa T, Mizuno Y, Fujita Y, Takatama M, Nakazato Y, Okamoto K. Optineurin in neurodegenerative diseases. Neuropathology. 2011;31:569-74.
12. Maekawa S, Leigh PN, King A, Jones E, Steele JC, Bodi I, et al. TDP-43 is consistently colocalized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations. Neuropathology. 2009;29: 672-83.
13. Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALSCBS). Amyotroph Lateral Scler. 2010;11:303-11.
14. Andersen PM, Nilsson P, Forsgren L, Marklund SL. Cu/Zn superoxide dismutase, extracellular-superoxide dismutase, and glutathione peroxidase in individuals homozygous for Asp90Ala Cu/Zn superoxide dismutase mutation. J Neurochem. 1998;70:715-20.
15. Stewart HG, Andersen PM, Eisen A, Weber M. Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutations. Clinical Neurophysiology. 2006;117:1850-61.
16. Eisen A, Mezei M, Stewart HG, Fabros M, Gibson G, Andersen PM. SOD1 gene mutations in ALS patients in British Columbia, Canada: Clinical features, neurophysiology and ethical issues in management. Amyotroph Lateral Scler. 2008;9:108-19.
17. Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011;7:603-15.
18. Lillo P, Garcin B, Hornberger M, Bak TH, Hodges Jr. Neurobehavioural features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol. 2010;67:826-30.